article Open AccessTop 1% cited
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Hepatology · 2023 · Vol. 78(6) · pp. 1922–1965
Amit G. Singal✉(The University of Texas Southwestern Medical Center)Josep M. Llovet(Institució Catalana de Recerca i Estudis Avançats)Mark Yarchoan(Sidney Kimmel Comprehensive Cancer Center)Neil Mehta(University of California, San Francisco)Julie K. Heimbach(Mayo Clinic)Laura A. Dawson(University Health Network)Janice H. Jou(Oregon Health & Science University)Laura Kulik(Northwestern Medical Faculty Foundation)Vatche G. Agopian(University of California, Los Angeles)Jorge A. Marrero(University of Pennsylvania)Mishal Mendiratta‐Lala(University of Michigan–Ann Arbor)Daniel B. Brown(Vanderbilt University Medical Center)William S. Rilling(Medical College of Wisconsin)Lipika Goyal(Stanford Medicine)Alice C. Wei(Memorial Sloan Kettering Cancer Center)Tamar H. Taddei(VA Connecticut Healthcare System)
Abstract
Singal, Amit G.; Llovet, Josep M.; Yarchoan, Mark; Mehta, Neil; Heimbach, Julie K.; Dawson, Laura A.; Jou, Janice H.; Kulik, Laura M.; Agopian, Vatche G.; Marrero, Jorge A.; Mendiratta-Lala, Mishal; Brown, Daniel B.; Rilling, William S.; Goyal, Lipika; Wei, Alice C.; Taddei, Tamar H. Author Information
Hepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentCancer, Lipids, and MetabolismHepatocellular carcinomaAlice (programming language)MedicinePhilosophyArtArt historyInternal medicine
MeSH terms
Contrast MediaCarcinoma, HepatocellularHumansLiver NeoplasmsTomography, X-Ray Computed
Funding
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- American Association for the Study of Liver Diseases
- Gilead Sciences
- Boston Scientific Corporation
- Exelixis
- Incyte
- Eisai
- Ipsen
- Sirtex Medical
- Genentech
Citations
1,480
FWCI
301.05
field-weighted impact
References
354
Percentile
100%
vs. same field & year
Citations per year
References
Sorafenib in Advanced Hepatocellular Carcinoma
New England Journal of Medicine · 2008 · 12,835 citations
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
Hepatology · 2003 · 3,004 citations
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
The Lancet Oncology · 2008 · 5,801 citations
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
European Journal of Cancer · 2011 · 570 citations
The International Position on Laparoscopic Liver Surgery
Annals of Surgery · 2009 · 1,505 citations
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
European Journal of Cancer · 2008 · 28,935 citations
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
Hepatology · 2002 · 2,609 citations
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
PLoS Medicine · 2014 · 806 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.